Tri Continental Closed Fund (TY) Peer Comparison
$35.70
As on 26-Aug-2026 16:00EDT
Market cap
$1,892 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
7.2
P/B Ratio
1
Div. Yield
3.1 %
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
1,892 | 3,291 | 2,089 | 1,649 | 1,599 |
Revenue ($ Mln) |
205 | 948 | 266 | 225 | 24 |
Net Profit ($ Mln) |
254.31 | -375.00 | 314.36 | 221.99 | 376.65 |
Net Margin (%) |
-- | -39.56 | -- | -- | 1,542.35 |
RoE (%) |
13.09 | -6.75 | 20.33 | 13.39 | 20.46 |
Price to Earnings |
7.24 | -- | 6.56 | 7.50 | 4.21 |
Price-To-Book |
0.98 | 0.65 | 1.22 | 1.04 | 0.93 |
Income Statement ($ Mln)
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
204.61 | 1,171.00 | 265.96 | 225.03 | 163.88 |
|
Cost of Revenue
|
8.19 | 356.00 | 20.58 | 1.43 | 13.88 |
|
Gross Profit
|
196.42 | 815.00 | 245.38 | 223.60 | 150.00 |
|
Operating Expenses
|
-57.89 | 235.00 | -69.41 | 1.61 | -189.78 |
|
Operating Profit (EBIT)
|
254.31 | 580.00 | 314.79 | 221.99 | 339.84 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
254.31 | 23.00 | 314.36 | 221.99 | 339.84 |
|
Provision for Tax
|
-- | 12.00 | -- | -- | -- |
|
Profit after Tax (Net Income)
|
254.31 | 11.00 | 314.36 | 221.99 | 339.84 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 11.00 | -- | -- | -- |
Liabilities ($ Mln)
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,982.80 | 5,849.00 | 1,717.10 | 1,595.29 | 1,756.14 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
2.44 | 7,880.00 | 18.50 | 93.32 | 16.88 |
|
Current Liabilities
|
2.04 | -- | 17.50 | 277.11 | 0.33 |
|
Total Liabilities
|
1,985.24 | 13,729.00 | 1,753.11 | 1,965.72 | 1,773.36 |
Assets ($ Mln)
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,972.27 | 13,548.00 | 1,721.20 | 1,958.96 | 1,772.94 |
|
Current Assets
|
12.97 | 181.00 | 31.91 | 6.75 | 0.42 |
|
Total Assets
|
1,985.24 | 13,729.00 | 1,753.11 | 1,965.72 | 1,773.36 |
|
Total Debt*
|
-- | 7,634.00 | 17.50 | -- | 1.80 |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-- | 592.00 | -47.75 | 329.51 | -- |
|
Cash Flow from Investing Activities
|
-- | 236.00 | 324.34 | -- | -- |
|
Cash from Financing Activities
|
-- | -679.00 | -256.13 | -- | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.09 | 0.08 | 20.17 | 13.39 | 20.56 |
|
ROE (%)
|
13.09 | 0.18 | 20.33 | 13.39 | 20.58 |
|
ROA (%)
|
13.07 | 0.08 | 18.21 | 11.41 | 20.36 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
124.29 | 0.94 | 118.20 | 98.65 | 207.37 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.36 | 0.05 | -0.03 | 0.14 | -0.35 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-20.71 | -98.12 | 15.45 | 14.18 | 38.45 |
|
EPS Growth (%)
|
-0.21 | -0.98 | -0.42 | -- | 0.35 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
6.87 | 377.07 | 4.94 | -- | 4.15 |
|
Price / Book Value
|
0.88 | 0.71 | 0.91 | -- | 0.80 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
6.87 | 17.44 | 4.90 | -- | 4.15 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 1.31 | 0.01 | -- | 0.00 |
|
Short term debt to equity ratio
|
-- | 0.00 | 0.01 | -- | -- |
|
Current Ratio
|
6.37 | -- | 1.82 | 0.02 | 1.26 |
|
Quick Ratio
|
-- | -- | -- | -- | -- |
|
Interest Coverage
|
-- | 1.05 | -- | -- | -- |
Operating Efficiency Ratios
| Tri Continental Closed Fund (TY) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
6.25 | 35.10 | 0.59 | -- | 1.57 |
|
Asset Turnover
|
0.11 | 0.08 | 0.15 | 0.12 | 0.10 |
|
Receivable days
|
21.00 | 122.27 | 1.18 | 18.07 | 15.90 |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
102.43 | 100.03 | 249.67 | 59,183.92 | 9.21 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |